Breyanzi (lisocabtagene maraleucel) - BMS
CAR T cell therapy - bluebird bio, Baylor Scott & White Research Institute, BMS
Actemra IV (tocilizumab) - Roche, JW Pharma
https://ebmt2021.abstractserver.com/program/#/details/presentations/1326
 
J.E. Godwin1; M. Maris2; D.A. Stevens3; D. Hoda4; B. Mattar5; J.C. Varela6; M. Cherry7; J. Essell8; J. Courtright9; S. Fanning10; H. Yimer11; N.S. Trede12; M. Youssef13; J. Lymp12; C. Bachier14
 
Feb 4, 2021
 
Prev Next